Hani Alothaid (H Alothaid)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Breast Cancer Cells

Genetic Diversity

Top Venues

Molecules (Basel, Switzerland)

Dose-response : a publication of International Hormesis Society

Oxidative medicine and cellular longevity

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mohsin Kazi, Athba Alqahtani, Majed Alharbi, Ajaz Ahmad, Muhammad Delwar Hussain, Hani Alothaid, Mohammed S Aldughaim
The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol. Molecules (Basel, Switzerland) 28 (3) (2023)
Hani Alothaid, Mashael R Al-Anazi, Arwa A Al-Qahtani, Dilek Colak, Azeez Yusuf, Mohammed S Aldughaim, Ali M Mahzari, Mahmoud M Habibullah, Saud Alarifi, Saad AlKahtani, Ahmed A Al-Qahtani
Exposure to Cadmium Telluride Quantum Dots and Gene Expression Profile of Huh-7 Hepatocellular Carcinoma Cell Line. Dose-response : a publication of International Hormesis Society 21 (3) (2023)
Mohsin Kazi, Athba Alqahtani, Majed Alharbi, Ajaz Ahmad, Muhammad Delwar Hussain, Hani Alothaid, Mohammed S Aldughaim
The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol. Molecules (Basel, Switzerland) 28 (3) (2023)
Mohsin Kazi, Athba Alqahtani, Majed Alharbi, Ajaz Ahmad, Muhammad Delwar Hussain, Hani Alothaid, Mohammed S Aldughaim
The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol. Molecules (Basel, Switzerland) 28 (3) (2023)
Ayyub A Patel, Keshav Tiwari, Purva Asrani, Hani Alothaid, A F A Alahmari, R Mirdad, Mohammad Rehan Ajmal, Mohammed Tarique
Glutaredoxin proteins from E. coli isoforms were compared in terms of energy frustration. Brazilian journal of biology = Revista brasleira de biologia 83 (2023)
Abdulrahman Tawfik, Abdulrahman Alzahrani, Sami Alharbi, Jamal Almitairi, Arwa Alzahrani, Mohammed Ali Alshehri, Mohammed S Aldughaim, Hani Alothaid
Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients. Advances in virology 2022 (2022)
Mahmoud M Habiballah, Syam Mohan, Nabeel Kashan Syed, Hafiz A Makeen, Qazi Mohammad Sajid Jamal, Hani Alothaid, Farkad Bantun, Alaa Alhazmi, Ali Hakamy, Yahia A Kaabi, Ghalia Samlan, Mohtashim Lohani, Neelaveni Thangavel, Mohamed Ahmed Al-Kasim
Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells. Drug design, development and therapy 16 (2022)
Saad M Bin Dajem, Md Atique Ahmed, Marie Fe F Bohol, Syeda Wasfeea Wazid, Mohammed I Shafeai, Fuad H Rudiny, Ali M Motaen, Kareem Morsy, Hani Alothaid, Ahmed Ali Al-Qahtani
Genetic Diversity, Repeat Motifs, and Natural Selection at the C-Terminal Knob-Associated Histidine Rich Protein (KAHRP) of Plasmodium falciparum Clinical Samples from Saudi Arabia. Journal of tropical medicine 2022 (2022)
Mohammed S Aldughaim, Mashael R Al-Anazi, Marie Fe F Bohol, Dilek Colak, Hani Alothaid, Salma Majid Wakil, Samya T Hagos, Daoud Ali, Saud Alarifi, Sashmita Rout, Saad Alkahtani, Mohammed N Al-Ahdal, Ahmed A Al-Qahtani
Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis. Dose-response : a publication of International Hormesis Society 19 (2) (2021)
Alaa U AlRuwaisan, Mashael R Al-Anazi, Mohammed I Shafeai, Fuad H Rudiny, Ali M Motaen, Saad M Bin Dajem, Hani Alothaid, Kareem Morsy, Saad AlKahtani, Ahmed Ali Al-Qahtani
Associations of Single Nucleotide Polymorphisms in IL-18 Gene with Plasmodium falciparum-Associated Malaria. Journal of inflammation research 14 (2021)
Saad AlKahtani, Saud Alarifi, Gadah Albasher, Mohammed Al-Zharani, Nada H Aljarba, Mohammed H Almarzoug, Norah M Alhoshani, Norah S Al-Johani, Hani Alothaid, Abdullah A Alkahtane
Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers. Oxidative medicine and cellular longevity 2021 (2021)